Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

It may be possible to treat type 1 diabetes simply by re-educating the immune system. Researchers at Stanford Medicine have ...

This summer, Norton Healthcare hopes to launch a new islet cell program to help treat chronic pancreatitis and eventually Type 1 diabetes patients.

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

Lantidra therapy infuses healthy islet cells into patients' livers, with some achieving insulin independence. University ...

An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) used its quarterly conference call to highlight a longer cash runway following ...

A vascularized organoid model of hormone-secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies. “Our results highlight the importance ...

Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified key trends in the types of cells ...

An investigational antibody could reduce the toxicity associated with immune suppression in islet cell transplantation for type 1 diabetes (T1D), according to new preliminary data. Six people with T1D ...

Obviously caveats must be drawn from a mouse model such as this, but the results have supercharged the team's determination.